Govt notifies norms to skip test licences for drug R&D to boost ease of doing business

The Union Health Ministry has eased pharmaceutical regulations, allowing companies to start drug development and low-risk ...

Govt eases drug R&D norms, allows pharma firms to skip test licences

Pharma companies will no longer ne required to seek a test licence and may proceed with pharmaceutical development upon submitting an online intimation to CDSCO, except in certain cases, as part of ...
The Week

Govt notifies norms to skip test licensing for drug R D to boost ease of doing business

Under the new regulations, pharmaceutical companies are no longer required to obtain a test licence for manufacturing drugs in small quantities for research and analysis, provided they submit an ...
Pharmabiz

Amendments to NDCT Rules, 2019 to reduce regulatory burden and promote EoDB, says health ministry

Amendments to NDCT Rules, 2019 to reduce regulatory burden and promote EoDB, says health ministry: Our Bureau, New Delhi Wednesday, January 28, 2026, 13:45 Hrs [IST] The Union min ...